Due in part to increasing rates of obesity, another major risk factor is emerging, metabolic dysfunction-associated steatotic ...

HCC risk prediction may be poorly reported and biased for individuals with nonviral chronic liver disease.

Sagimet Biosciences eyes major opportunities in MASH and Acne treatments. Find out why SGMT stock is a solid pick with upcoming phase 3 study results.

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...

Altimmune’s lead drug Pemvidutide demonstrates significant progress in obesity and liver health. See why ALT stock is a ...

Discover a new study that has examined the influence of clinical and histologic risk factors on long-term MASLD outcomes in ...

MASLD diagnosis was associated with an increased risk for youth-onset type 2 diabetes among pediatric patients with obesity.

Eating high-fat dairy products which include whole milk, cream, frozen yoghurt, butter, and ghee, may increase the risk of ...

This review discussed experimental mouse models used in the pre-clinical study of liver fibrosis regression, a pivotal ...

Children with obesity and metabolic dysfunction–associated steatotic liver disease (MASLD) have a higher risk for youth-onset type 2 diabetes (T2D), and the risk increases dramatically in the ...

The success surrounding the medications for obesity and diabetes has sparked research into whether they could also be an ...

Liver diseases are any diseases that affect the functioning of the liver. Liver diseases can be inherited (such as Wilson disease and alpha 1-antitrypsin deficiency) or acquired (for example ...